Primær Hyperkolesterolæmi og Kombineret Hyperlipidæmi I undersøgelser der sammenligner effekt og sikkerhed af simvastatin 10, 20, 40 og 80 mg dagligt hos patienter med hyperkolesterolæmi, var de gennemsnitlige LDL- C reduktioner på henholdsvis 30, 38, 41 og 47%.
Primary Hypercholesterolaemia and Combined Hyperlipidaemia In studies comparing the efficacy and safety of simvastatin 10, 20, 40 and 80 mg daily in patients with hypercholesterolemia, the mean reductions of LDL-C were 30, 38, 41 and 47%, respectively.